How to help patients get better control of their IBDCanadian study concludes further strategies are needed for better control of inflammatory bowel diseases and improved quality of life. NEW DRUG: Velsipity for ulcerative colitisGet the info you need on this new product, part of our drug news roundup for July. Video series informs pharmacists about management of GERD The three-part series is the latest from the International Pharmaceutical Federation. QUIZ: Do you know what actually contains gluten? If you have patients with celiac disease or a gluten allergy or intolerance, how do you counsel them about dietary concerns? Salty foods are making people sick—in part by poisoning their microbiomes How might a substance previously thought worth its weight in gold have transformed into something many medical institutions consider a key predictor of disease? Perforated appendicitis detected earlier in children thanks to genetic markers Earlier diagnosis and treatment can lead to better outcomes. Common sense facts on gut, stomach health Pharmacist offers new evidence-based resource on how to improve microbiome with latest book. Celiac disease and non-celiac gluten/wheat sensitivity: What’s the difference? It’s estimated that most Canadians with celiac disease don’t know they have it. GLP-1 receptor agonist use may reduce quality of colonoscopy bowel preparation Glucagon-like peptide-1 receptor agonists, commonly used for diabetes and obesity management, are known to slow gastrointestinal motility. Antibiotics and acid suppressants may be behind increased pediatric eosinophilic esophagitis Danish study found a 40% to 80% increased risk. First Previous 1 2 3 4 5 Next Last
